AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT

ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT ENSURE QUALITY WITH RISK ASSESSMENT Agilent Solutions Help You Evaluate CQAs Critical quality attributes for drug substances typically include those properties or characteristics that affect identity, purity, biological activity, and stability.…

QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology Application Note Pharmaceutical QA/QC Author Abstract Vinayak A.K In this Application Note, a method was developed…

Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application Note Pharmaceutical Developments and QA/QC Authors Abstract Vinayak A.K and Andreas Tei This…

Quality-by-Design Approach to Stability Indicating Method Development for Linagliptin Drug Product Application Note Pharmaceutical QA/QC Authors Abstract Syed Salman Lateef and Vinayak AK A traditional approach to method development could fail to meet desired Agilent Technologies, Inc. separation during validation,…